Full Sail Capital, LLC Abb Vie Inc. Transaction History

Full Sail Capital, LLC

  • $1.55 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$138.31 - $165.87 $200,411 - $240,345
1,449 New
1,449 $234,000
Q1 2019

May 16, 2019
SELL
$77.14 - $90.79 $197,864 - $232,876
-2,565 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$77.85 - $96.01 $199,685 - $246,265
2,565 New
2,565 $236,000

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Full Sail Capital, LLC Portfolio

Follow Full Sail Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Full Sail Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email